Puma Biotechnology Inc (PBYI) — Cash Flow Quality Index
Puma Biotechnology Inc (PBYI) has a Cash Flow Quality Index of 1.22x as of December 2025. Operating cash flow of $14.42 Million exceeds net income of $11.80 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Puma Biotechnology Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Puma Biotechnology Inc Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for Puma Biotechnology Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Puma Biotechnology Inc generate cash.
Annual Cash Flow Quality Index for Puma Biotechnology Inc (2022–2025)
Year-by-year earnings quality comparison for Puma Biotechnology Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.34x | $41.80 Million | $31.11 Million | ▲ +4.5% |
| 2024 | 1.29x | $38.92 Million | $30.28 Million | ▲ +2.8% |
| 2023 | 1.25x | $27.01 Million | $21.59 Million | ▲ +100.0% |
| 2022 | -7913.50x | $-15.83 Million | $2.00K | — |